What You Should Know:
– This strategic move strengthens Veradigm’s position as a premier provider of RCM services in the ambulatory healthcare market. Financial details of the acquisition were not dislcosed.
Expanding Ambulatory RCM Expertise and Reach
The acquisition brings significant advantages for both companies:
Enhanced MSK Expertise: Koha’s specialized knowledge in Musculoskeletal Medicine (MSK) adds depth and breadth to Veradigm’s RCM offerings, catering to a growing and crucial healthcare sector.
Widened Service Scope: Veradigm gains the ability to serve a broader range of clients, including ambulatory healthcare provider practices and Ambulatory Surgical Centers (ASCs) utilizing diverse EHR systems.
End-to-End RCM Portfolio: Veradigm bolsters its RCM suite, providing clients with a comprehensive solution encompassing the entire revenue cycle, from claims management to reimbursement.
This move not only strengthens Veradigm’s existing client base but also unlocks new market opportunities, particularly in the MSK and diverse EHR segments. By providing clients with added value through a comprehensive and specialized RCM solution, Veradigm aims to drive growth and success for both the company and its partner healthcare providers.
“Today’s announcement represents an exciting opportunity for Veradigm to scale our revenue cycle services portfolio by leveraging additional capabilities and subject matter expertise to better serve the needs of the market,” said Tom Langan, President, and Chief Commercial Officer at Veradigm.